Impact of lymph node staging on therapy of esophageal carcinoma Enrique Vazquez-Sequeiros, Maurits J Wiersema, Jonathan E Clain, Ian D Norton, Michael J Levy, Yvonne Romero, Diva Salomao, Ross Dierkhising, Alan R Zinsmeister  Gastroenterology  Volume 125, Issue 6, Pages 1626-1635 (December 2003) DOI: 10.1053/j.gastro.2003.08.036

Figure 1 Algorithm for selection of lymph nodes undergoing EUS FNA. When more than one lymph node was identified in a specific location, the one with the greater number of malignant EUS criteria (more suspicious) was initially selected for EUS FNA. The procedure was terminated if either suspicious cells were found on the smear or no additional lymph nodes were found on the EUS examination. Gastroenterology 2003 125, 1626-1635DOI: (10.1053/j.gastro.2003.08.036)

Figure 2 Flow diagram showing the specific number of patients who underwent EUS FNA in each of these specific anatomic regions: celiac axis lymph node, nonperitumoral perigastric lymph node, and nonperitumoral periesophageal lymph node. Gastroenterology 2003 125, 1626-1635DOI: (10.1053/j.gastro.2003.08.036)